ARROWHEAD PHARMACEUTICALS, INC.
Develops RNAi medicines to silence genes causing intractable cardiometabolic and pulmonary diseases.
ARWR | US
Overview
Corporate Details
- ISIN(s):
- US04280A1007
- LEI:
- Country:
- United States of America
- Address:
- 177 E COLORADO BLVD, 91105 PASADENA
- Website:
- https://arrowheadpharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company that develops medicines to treat intractable diseases by silencing the genes that cause them. The company's core technology is its proprietary Targeted RNAi Molecule (TRiM™) platform, which utilizes RNA interference (RNAi) to induce rapid, deep, and durable suppression of specific target genes. Arrowhead's clinical pipeline is focused on a broad range of therapeutic areas, including cardiometabolic, pulmonary, neuromuscular, and liver diseases, such as hepatitis B and alpha-1 antitrypsin deficiency-associated liver disease. The company emphasizes accelerating the development of its innovative therapies from discovery to the clinic to address unmet patient needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ARROWHEAD PHARMACEUTICALS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ARROWHEAD PHARMACEUTICALS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ARROWHEAD PHARMACEUTICALS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
